Patents

Description

DERIVAŢI SUBSTITUIŢI DE PIPERIDINĂ, COMPOZIŢII FARMACEUTICE CARE ÎI CONŢIN ŞI UTILIZAREA ACESTORA CA ANTIPSIHOTICE ŞI ANALGEZICE

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO120341

Date: 30.12.2005

Inventor(s):

STRUPCZEWSKI JOSEPH [US]

HELSLEY C GROVER [US]

GLAMKOWSKI J EDWARD [US]

CHIANG YULIN [US]

BORDEAU J KENNETH [US]

NEMOTO PETER A [US]

TEGELER JOHN J [US]

Applicant(s):
HOECHST ROUSSEL PHARMA [US]
Classification:
International patent classification (IPC):
A61K31/415; A61K31/42; A61K31/425; A61K31/44; A61K31/4427; A61K31/445; A61K31/4453; A61K31/47; A61K31/495; A61K31/496; A61K31/505; A61K31/55; A61P23/00; A61P25/00; A61P25/04; A61P25/18; C07C233/25; C07C233/33; C07C255/54; C07C323/22; C07C45/45; C07C45/67; C07C45/71; C07C49/84; C07D207/08; C07D221/04; C07D231/56; C07D239/02; C07D261/20; C07D275/04; C07D275/06; C07D277/82; C07D401/00; C07D401/04; C07D401/12; C07D401/14; C07D403/00; C07D403/04; C07D403/12; C07D403/14; C07D405/04; C07D413/04; C07D413/12; C07D413/14; C07D417/00; C07D417/04; C07D417/14; C07D419/00; C07D471/04; C07F7/18
Cooperative patent classification (CPC):
A61K31/41 (KR); A61K31/495 (KR); A61P23/00 (EP); A61P25/00 (EP); A61P25/04 (EP); A61P25/18 (EP); A61P29/00 (EP); C07C233/25 (EP); C07C233/33 (EP); C07C255/54 (EP); C07C323/22 (EP); C07C45/45 (EP); C07C45/673 (EP); C07C45/71 (EP); C07D207/08 (EP); C07D231/56 (EP); C07D261/20 (EP); C07D275/04 (EP); C07D275/06 (EP); C07D277/82 (EP); C07D401/04 (EP); C07D401/12 (EP); C07D401/14 (EP); C07D403/12 (EP); C07D413/04 (EP); C07D413/12 (EP); C07D413/14 (EP); C07D417/04 (EP, KR); C07D417/14 (EP); C07D471/04 (EP); C07F7/1804 (EP); C07C45/45; C07C49/84; C07C45/673; C07C45/71; C07C47/575; C07C49/755
Application info:
No.: RO19960000888
Date: 27.10.1994
Priority number(s):
US19930144265 28.10.1993 ; US19940329000 25.10.1994 ; WO1994US12054 27.10.1994
Related patents:
AU8122894; CA2175212; CN1136275; CN1143675; CZ123896; CZ295927; EP0730452; EP2311824; JPH09511215; KR100743848; KR100795867; KR20040004478; KR960705819; NO306994; NO961686; NZ275941; PL181059; PL314135; RU2216545; US5550130; US5552414; US5554614; US5556858; US5559116; US5559117; US5559126; US5569653; US5571803; US5571814; US5571828; US5574032; US5578605; US5578624; US5580875; US5580879; US5580886; US5580887; US5580890; US5580891; US5583145; US5589488; US5589494; US5589495; US5591745; US5593995; US5597842; US5599821; US5602158; US5602159; US5605913; US5607945; US5612342; US5612343; US5614543; US5624927; US5629326; US5633265; US5637710; US5639764; US5646161; US5648363; US5652241; US5654319; US5663449; US5776963; US5811430; US5811435; US5840727; US5843949; US5843977; US5854243; US5854263; US5874435; US5889004; US5889035; US5919798; US5965546; US5977113; US5977140; US5998417; US6001834; US6043240; US6110938; US6140345; US6207680; US6251907; US6420390; USRE37029; USRE37478; USRE37729; WO9511680
Description:

Invenţia se referă la următorii derivaţi de piperidină: 1-4-[3-[4-(6-fluoro-1,2-benzizoxazol-3-il)-1-piperidinil]propoxi-3-metoxi-fenil]-2-hidroxietanonă, sau o sare de adiţie acidă corespunzătoare, acceptabilă farmaceutic, 4-[3-[4-(6-fluoro-1,2-benzizoxazol-3-il)-1-piperidinil]propoxi]-2-hidroxi-5-metoxi-alfa-metilbenzenmetanol, sau o sare de adiţie acidă corespunzătoare, acceptabilă farmaceutic şi 1-4-[3-[4-fluoro-1,2-benzizoxazol-3-il)-1-piperidinil]propoxi]-2-hidroxi-5-metoxifenil]etanonă, sau o sare de adiţie acidă corespunzătoare, acceptabilă farmaceutic, la compoziţii farmaceutice, antipsihotice, analgezice şi de depozit, care cuprind aceşti compuşi şi la utilizările acestor compuşi, ca antipsihotice sau analgezice.

Share this on:
Facebook Twitter/X LinkedIn Whatsapp Email